EGFR-IN-57

Modify Date: 2024-01-08 17:15:24

EGFR-IN-57 Structure
EGFR-IN-57 structure
Common Name EGFR-IN-57
CAS Number 2492382-37-1 Molecular Weight 385.44
Density N/A Boiling Point N/A
Molecular Formula C22H15N3O2S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of EGFR-IN-57


EGFR-IN-57 (Compound 25a) is a potent, orally active EGFR-TK inhibitor with an IC50 of 0.054 µM. EGFR-IN-57 also inhibits VEGFR-2, CK2α, topoisomerase IIβ and tubulin polymerization with IC50 values of 0.087, 0.171, 0.13 and 3.61 µM, respectively. EGFR-IN-57 induces cell cycle arrest at G2/M and pre-G1 phases. EGFR-IN-57 induces cancer cell apoptosis[1].

 Names

Name EGFR-IN-57

 EGFR-IN-57 Biological Activity

Description EGFR-IN-57 (Compound 25a) is a potent, orally active EGFR-TK inhibitor with an IC50 of 0.054 µM. EGFR-IN-57 also inhibits VEGFR-2, CK2α, topoisomerase IIβ and tubulin polymerization with IC50 values of 0.087, 0.171, 0.13 and 3.61 µM, respectively. EGFR-IN-57 induces cell cycle arrest at G2/M and pre-G1 phases. EGFR-IN-57 induces cancer cell apoptosis[1].
Related Catalog
Target

EGFR:0.054 μM (IC50)

VEGFR-2:0.087 μM (IC50)

CK2α:0.171 μM (IC50)

topoisomerase II beta:0.13 μM (IC50)

tubulin polymerization:3.16 μM (IC50)

References

[1]. Warda ET, et al. New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation. Bioorg Med Chem. 2020 Nov 1;28(21):115674.

 Chemical & Physical Properties

Molecular Formula C22H15N3O2S
Molecular Weight 385.44